focus -WSS

focus

author：entertainment 2025-09-06 03:53:03 - browse：3252

New Sanofi Genzyme president Bill Sibold is the first person without any ties to Henri Termeer (inset) to lead the company. Jonathan Wiggs/Globe staff

CAMBRIDGE, Mass. — When drug giant Sanofi restructured its global business two years ago, its Genzyme division got a new name, Sanofi Genzyme, explicitly tying it to the French parent company. It also got new responsibilities and a larger “specialty care” portfolio covering everything from enzyme replacement to cancer and multiple sclerosis drugs.

Last week, Sanofi Genzyme — still the largest Massachusetts biotech, with about 5,000 workers — also got a new president, Bill Sibold. He’s the first one without any ties to the old Genzyme, an independent company that pioneered the rare-disease business model and catalyzed the local life sciences boom before accepting Sanofi’s $20.1 billion takeover offer in 2011.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Driven by the pandemic, applicants flood public health schools

WSS

How to improve immunocompromised access to mAb treatments

Jury awards Florida girl burned by McDonald's Chicken McNugget $800,000 in damages

First recipient of genetically engineered pig kidney has died

Readout LOUD podcast: What to know about H5N1 bird flu

Affordable Connectivity Program vital to health care, experts say

Telehealth startups turn to complex chronic diseases

knowledge

focus

explore

Medicare proposal to cover medical devices draws a mixed reaction

Indian pharmaceutical industry in denial over drug

Jerome Adams on the need for new antivirals for Covid

Bird flu outbreak in cows is latest avian flu curveball

United colonoscopy coverage change 'may cost lives,' doctors say

Driven by the pandemic, applicants flood public health schools

Apple is now the first public company to be valued at $3 trillion

What nurses really want: sufficient staffing for patient care

Continuity nursing helped my family in our darkest PICU moments

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

focus

H5N1 bird flu: what we're starting to learn about infection in cows

Senate committee advances SCOTUS ethics bill after alleged justice misconduct

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

7 more heat

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Wikipedia

focus

focus

hotspot